Orca graft transplant
WebOct 14, 2024 · Orca-T is an investigational allogeneic, high-precision cell therapy for patients with blood cancers who are eligible for a hematopoietic (blood) stem cell transplant. In … WebAug 2, 2024 · Orca Bio Announces the Precision-T Phase 3 Study is Open and Enrolling Patients at Transplant Centers Across the U.S. August 2, 2024, 9:00 AM · 4 min read – The pivotal Precision-T Study is...
Orca graft transplant
Did you know?
WebFeb 23, 2024 · The Orca-T–treated patients had a median age of 47 and 52% were male. Indications for transplant included acute myeloid and acute lymphoblastic leukemia, chronic myeloid leukemia, B-cell lymphoma, myelodysplastic syndrome/myelofibrosis, and other unspecified indications. WebJan 28, 2024 · The impressive clinical activity demonstrated with Orca-T, a high-precision allogeneic cellular therapy, has been mirrored in both single-institution and multicenter trials, highlighting the void...
WebOct 1, 2024 · The precision cellular therapy, Orca-T, demonstrated improvement in 1-year graft-versus-host disease (GVHD)-free relapse-free survival (GRFS) compared with standard transplant following myeloablative conditioning (MAC) for hematological malignancies, according to findings from 2 studies. 1 The findings were presented by Samer Srour, … WebFeb 8, 2024 · Treatment with Orca-T, a high-precision cell therapy, demonstrated a reduction in graft-vs-host disease (GVHD) and non-relapse mortality (NRM) rates, while also producing higher than expected...
WebJan 14, 2024 · A Phase 1, Dose Escalation and Expansion Study of Engineered Donor Grafts Derived From Mobilized Peripheral Blood (Orca-Q, Formerly OrcaGraft), With Single …
WebDec 6, 2024 · Orca-T is an investigational new drug with the potential to dramatically reduce the complications of bone marrow transplants such as GvHD and bring curative outcomes …
WebAn allogeneic stem cell transplant has been the best hope for many patients fighting serious illnesses, such as blood cancers, since the procedure was first performed more than 50 years ago. ... Graft-Versus-Host Disease. Published August 2024. FS32. At Orca Bio, we don’t accept these limitations, and we believe patients shouldn’t have to ... ts4 the outsiders ccWebJul 10, 2024 · A Study of Engineered Donor Grafts (Orca-T) in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies. The safety and scientific … ts4 the best modsWebOver one million people in the world today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many patients, the transplant itself can prove fatal or lead to serious conditions, such as graft versus host disease.Orca Bio's investigational, high-precision cell therapies are designed to replace a patient's … phillips way finksburgWebAug 2, 2024 · Orca-T is a first-in-class high-precision cell therapy that combines purified cells from a matched donor. It is designed to replace a patient's diseased blood and immune system with a healthy one while lowering the risk of developing GvHD and other life-threatening transplant-related side effects. phillips waterproofing louisville kyWebWhile a traditional allogeneic stem cell transplant has been the best hope for many patients, the transplant itself can prove fatal or lead to serious conditions, such as graft versus host disease ... ts4 tiana ccWebNov 5, 2024 · Finally, when compared to standard allo SCT, Orca-T recipients may have a reduced frequency and severity of infections without significant consequences while the SOC patients had severe and often multiple infections. Conclusion: Our data indicates that Orca-T graft was well tolerated and potentially efficacious in MF patients undergoing allo … phillips wayWebPurpose. This study will evaluate the safety, tolerability, and efficacy of an engineered donor graft ("TregGraft"/"Orca-T", a T-cell-Depleted Graft With Additional Infusion of Conventional T Cells and Regulatory T Cells) in participants undergoing myeloablative allogeneic hematopoietic cell transplant transplantation for hematologic malignancies. ts4 tights